Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

The serum heart-type fatty acid-binding protein (HFABP) levels can be used to detect the presence of acute kidney injury on admission in patients admitted to the non-surgical intensive care unit.

Shirakabe A, Kobayashi N, Hata N, Shinada T, Tomita K, Tsurumi M, Okazaki H, Matsushita M, Yamamoto Y, Yokoyama S, Asai K, Shimizu W.

BMC Cardiovasc Disord. 2016 Sep 5;16(1):174. doi: 10.1186/s12872-016-0340-1.

2.

Biomarkers of acute kidney injury and associations with short- and long-term outcomes.

Schaub JA, Parikh CR.

F1000Res. 2016 May 24;5. pii: F1000 Faculty Rev-986. doi: 10.12688/f1000research.7998.1. Review.

3.

Long-term remote organ consequences following acute kidney injury.

Shiao CC, Wu PC, Huang TM, Lai TS, Yang WS, Wu CH, Lai CF, Wu VC, Chu TS, Wu KD; National Taiwan University Hospital Study Group on Acute Renal Failure (NSARF) and the Taiwan Consortium for Acute Kidney Injury and Renal Diseases (CAKs)..

Crit Care. 2015 Dec 28;19:438. doi: 10.1186/s13054-015-1149-5.

4.

Comparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury.

Schley G, Köberle C, Manuilova E, Rutz S, Forster C, Weyand M, Formentini I, Kientsch-Engel R, Eckardt KU, Willam C.

PLoS One. 2015 Dec 15;10(12):e0145042. doi: 10.1371/journal.pone.0145042.

5.

Intra-abdominal hypertension does not predict renal recovery or in-hospital mortality in critically ill patients with acute kidney injury.

Chang HJ, Yang J, Kim SC, Kim MG, Jo SK, Cho WY, Kim HK.

Kidney Res Clin Pract. 2015 Jun;34(2):103-8. doi: 10.1016/j.krcp.2015.03.004.

6.

Evaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study.

Yamashita T, Doi K, Hamasaki Y, Matsubara T, Ishii T, Yahagi N, Nangaku M, Noiri E.

Crit Care. 2014 Dec 19;18(6):716. doi: 10.1186/s13054-014-0716-5.

7.

Academic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery Network.

Stawicki SP, Stoltzfus JC, Aggarwal P, Bhoi S, Bhatt S, Kalra OP, Bhalla A, Hoey BA, Galwankar SC, Paladino L, Papadimos TJ.

Int J Crit Illn Inj Sci. 2014 Jul;4(3):200-8. doi: 10.4103/2229-5151.141398.

8.

Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury.

Parr SK, Clark AJ, Bian A, Shintani AK, Wickersham NE, Ware LB, Ikizler TA, Siew ED.

Kidney Int. 2015 Mar;87(3):640-8. doi: 10.1038/ki.2014.301.

9.

Urine YKL-40 is associated with progressive acute kidney injury or death in hospitalized patients.

Hall IE, Stern EP, Cantley LG, Elias JA, Parikh CR.

BMC Nephrol. 2014 Aug 15;15:133. doi: 10.1186/1471-2369-15-133.

10.

Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications.

Alge JL, Arthur JM.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):147-55. doi: 10.2215/CJN.12191213. Review.

11.

Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients.

Matsa R, Ashley E, Sharma V, Walden AP, Keating L.

Crit Care. 2014 Jul 1;18(4):R137. doi: 10.1186/cc13958.

12.

Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit.

Doi K, Noiri E, Nangaku M, Yahagi N, Jayakumar C, Ramesh G.

Nephrol Dial Transplant. 2014 Jan;29(1):73-80. doi: 10.1093/ndt/gft414.

13.

Distinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function.

Siew ED, Ware LB, Bian A, Shintani A, Eden SK, Wickersham N, Cripps B, Ikizler TA.

Kidney Int. 2013 Oct;84(4):786-94. doi: 10.1038/ki.2013.174.

14.

Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI).

McCullough PA, Bouchard J, Waikar SS, Siew ED, Endre ZH, Goldstein SL, Koyner JL, Macedo E, Doi K, Di Somma S, Lewington A, Thadhani R, Chakravarthi R, Ice C, Okusa MD, Duranteau J, Doran P, Yang L, Jaber BL, Meehan S, Kellum JA, Haase M, Murray PT, Cruz D, Maisel A, Bagshaw SM, Chawla LS, Mehta RL, Shaw AD, Ronco C.

Contrib Nephrol. 2013;182:5-12. doi: 10.1159/000349962.

15.

Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients.

Hjortrup PB, Haase N, Wetterslev M, Perner A.

Crit Care. 2013 Apr 24;17(2):211. doi: 10.1186/cc11855. Review.

16.

Diagnostic accuracy of early urinary index changes in differentiating transient from persistent acute kidney injury in critically ill patients: multicenter cohort study.

Pons B, Lautrette A, Oziel J, Dellamonica J, Vermesch R, Ezingeard E, Mariat C, Bernardin G, Zeni F, Cohen Y, Tardy B, Souweine B, Vincent F, Darmon M.

Crit Care. 2013 Mar 26;17(2):R56. doi: 10.1186/cc12582.

17.

Semaphorin 3A is a new early diagnostic biomarker of experimental and pediatric acute kidney injury.

Jayakumar C, Ranganathan P, Devarajan P, Krawczeski CD, Looney S, Ramesh G.

PLoS One. 2013;8(3):e58446. doi: 10.1371/journal.pone.0058446.

18.

Additive value of blood neutrophil gelatinase-associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department.

Di Somma S, Magrini L, De Berardinis B, Marino R, Ferri E, Moscatelli P, Ballarino P, Carpinteri G, Noto P, Gliozzo B, Paladino L, Di Stasio E.

Crit Care. 2013 Feb 12;17(1):R29. doi: 10.1186/cc12510.

19.

The role of urinary liver-type fatty acid-binding protein in critically ill patients.

Cho E, Yang HN, Jo SK, Cho WY, Kim HK.

J Korean Med Sci. 2013 Jan;28(1):100-5. doi: 10.3346/jkms.2013.28.1.100.

20.

Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS).

Oboho I, Abraham AG, Benning L, Anastos K, Sharma A, Young M, Burian P, Gandhi M, Cohen M, Szczech L.

J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):388-95. doi: 10.1097/QAI.0b013e31828175c9.

Items per page

Supplemental Content

Support Center